Paper36913345
Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections.
Sarker B and 7 others. PLoS One, 2023. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections. Papers, record 36913345. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36913345
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Proscillaridin | Major topic |
| MicroRNAs | Major topic |
| Humans | |
| Transcriptome | |
| SARS-CoV-2 | |
| Molecular Docking Simulation | |
| Aurora Kinase A | |
| Gene Regulatory Networks | |
| Biomarkers | |
| Genomics | |
| COVID-19 Testing |
Source PubMed
References119
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25428367 | Prediction of DNA binding motifs from 3D models of transcription factors; identifying TLX3 regulated genes. | Nucleic Acids Res | 2014 | https://conductscience.org/library/papers/25428367 | PubMed |
| 2 | 32191675 | WHO Declares COVID-19 a Pandemic. | Acta Biomed | 2020 | https://conductscience.org/library/papers/32191675 | PubMed |
| 3 | 22889332 | Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. | J Cheminform | 2012 | https://conductscience.org/library/papers/22889332 | PubMed |
| 4 | 33839760 | Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19. | Brief Bioinform | 2021 | https://conductscience.org/library/papers/33839760 | PubMed |
| 5 | 32015507 | A pneumonia outbreak associated with a new coronavirus of probable bat origin. | Nature | 2020 | https://conductscience.org/library/papers/32015507 | PubMed |
| 6 | 35891565 | Network Pharmacology and Molecular Docking Elucidate the Underlying Pharmacological Mechanisms of the Herb Houttuynia cordata in Treating Pneumonia Caused by SARS-CoV-2. | Viruses | 2022 | https://conductscience.org/library/papers/35891565 | PubMed |
| 7 | 30371825 | PubChem 2019 update: improved access to chemical data. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/30371825 | PubMed |
| 8 | 22257669 | The sva package for removing batch effects and other unwanted variation in high-throughput experiments. | Bioinformatics | 2012 | https://conductscience.org/library/papers/22257669 | PubMed |
| 9 | 33228475 | Computational gene expression profiling in the exploration of biomarkers, non-coding functional RNAs and drug perturbagens for COVID-19. | J Biomol Struct Dyn | 2022 | https://conductscience.org/library/papers/33228475 | PubMed |
| 10 | 32292689 | Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. | Acta Pharm Sin B | 2020 | https://conductscience.org/library/papers/32292689 | PubMed |
| 11 | 15116359 | Development and testing of a general amber force field. | J Comput Chem | 2004 | https://conductscience.org/library/papers/15116359 | PubMed |
| 12 | 33930329 | Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context. | Lancet Respir Med | 2021 | https://conductscience.org/library/papers/33930329 | PubMed |
| 13 | 32366720 | Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/32366720 | PubMed |
| 14 | 32187464 | A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32187464 | PubMed |
| 15 | 34075346 | Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir. | ACS Cent Sci | 2021 | https://conductscience.org/library/papers/34075346 | PubMed |
| 16 | 32838660 | Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2. | J Biomol Struct Dyn | 2022 | https://conductscience.org/library/papers/32838660 | PubMed |
| 17 | 33781216 | Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak. | BMC Infect Dis | 2021 | https://conductscience.org/library/papers/33781216 | PubMed |
| 18 | 32397643 | Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA. | Viruses | 2020 | https://conductscience.org/library/papers/32397643 | PubMed |
| 19 | 33688586 | In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors. | Heliyon | 2021 | https://conductscience.org/library/papers/33688586 | PubMed |
| 20 | 32984567 | A SARS-CoV-2 host infection model network based on genomic human Transcription Factors (TFs) depletion. | Heliyon | 2020 | https://conductscience.org/library/papers/32984567 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41446353 | Discovery of Essential Genes as Possible Targets for Prostate Cancer Drug Development. | Int J Genomics | 2025 | https://conductscience.org/library/papers/41446353 | PubMed |
| 41227320 | Altered DNA Methylation Pattern Contributes to Differential Epigenetic Immune Signaling in the Upper Respiratory Airway of Unvaccinated COVID-19 Patients. | Cells | 2025 | https://conductscience.org/library/papers/41227320 | PubMed |
| 39585882 | Exploring bacterial key genes and therapeutic agents for breast cancer among the Ghanaian female population: Insights from In Silico analyses. | PLoS One | 2024 | https://conductscience.org/library/papers/39585882 | PubMed |
| 39024368 | In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing. | PLoS One | 2024 | https://conductscience.org/library/papers/39024368 | PubMed |
| 38675393 | Discovery of Bacterial Key Genes from 16S rRNA-Seq Profiles That Are Associated with the Complications of SARS-CoV-2 Infections and Provide Therapeutic Indications. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38675393 | PubMed |
Genes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36913345
GET https://conductscience.org/api/papers/v1/36913345/references?page=2